ArticleMedComm2024

Patient-derived ovarian cancer organoid carries immune microenvironment and blood vessel keeping high response to cisplatin.

Yuqing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.